CC
VERA icon

Commodore Capital’s Vera Therapeutics VERA Stock Holding History

Commodore Capital’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-800,000
Closed -$18.8M – 40
2025
Q2 		$18.8M Sell
800,000
-1,761,782
-69% -$39.6M 1.33% 21
2025
Q1 		$61.5M Buy
2,561,782
+603,182
+31% +$19.4M 4.53% 9
2024
Q4 		$82.8M Sell
1,958,600
-516,400
-21% -$22.9M 6.07% 6
2024
Q3 		$109M Hold
2,475,000
– – 6.84% 2
2024
Q2 		$89.5M Sell
2,475,000
-690,000
-22% -$27.4M 6.11% 6
2024
Q1 		$136M Sell
3,165,000
-2,285,000
-42% -$81.4M 9.13% 2
2023
Q4 		$83.8M Hold
5,450,000
– – 7.32% 4
2023
Q3 		$74.7M Hold
5,450,000
– – 8.73% 2
2023
Q2 		$87.5M Buy
5,450,000
+2,625,971
+93% +$23.7M 9.83% 2
2023
Q1 		$21.9M Buy
+2,824,029
New +$21.8M 3.34% 11

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commodore Capital's VERA Position: Q3 2025 in Review

Commodore Capital sold out of Vera Therapeutics (VERA) in Q3 2025, closing a stake of 800,000 shares — an estimated $18.8M sold.

Commodore Capital first reported a position in VERA in Q1 2023 and held it in 10 quarters. The position peaked at $136M in Q1 2024. 175 funds tracked by Wall St. Rank hold VERA as of Q3 2025.

  • Commodore Capital reported no remaining Vera Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Commodore Capital sold 800,000 Vera Therapeutics shares in Q3 2025, an estimated $18.8M.
  • Commodore Capital first reported a position in Vera Therapeutics in Q1 2023 and held it in 10 quarters.
  • Commodore Capital's Vera Therapeutics position peaked at $136M in Q1 2024.
  • 175 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2025.

Based on Commodore Capital's 13F filing for Q3 2025, filed 14 Nov 2025.